Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DCC4264 Protac_erralpha

Proteolysis targeting chimeras (PROTAC), providing broad tissue distribution and knockdown of the targeted ERRalpha protein in tumor xenografts

DCC4265 Protac_ripk2

Proteolysis targeting chimeras (PROTAC), providing broad tissue distribution and knockdown of the targeted RIPK2 protein in tumor xenografts

1801547-16-9
DCC4266 Protac-12

Novel SirReal-based PROTAC, inducing isotype-selective Sirt2 degradation, resulting in the hyperacetylation of the microtubule network coupled with enhanced process elongation

DCC4267 Protac-3 (fak)

Novel selective and potent Fak degrader

DCC4268 Protac-6c

The most potent and selective ERRα degrader

DCC4269 Protac-i

Novel PROTAC, targeting steroid hormone receptors for ubiquitination and degradation

1448189-04-5
DCC4270 Protegenin A

Novel bacterial polyyne contributing to the antioomycete and plant-protective effects of P. protegens

DCC4271 Prs-211375

Novel selective CB2 agonist (CB2: 17.4 nM and CB1: 5585 nM)

573981-31-4
DCC4272 Pr-snf

Novel potent and selective inhibitor of SETD2

DCC4273 Prucalopride Hydrochloride

Selective 5-HT4 agonist

179474-80-7
DCC4274 Prx-07034

Novel selective 5-HT6 receptor antagonist, enhancing cognition and memory and potently decreasing food intake and body weight in rodents

903580-39-2
DCC4275 Prx-08066 Maleate

Novel potent and selective 5-HT2B receptor antagonist

866206-55-5
DCC4276 Ps1145 Dihydrochloride

Novel inhibitor of upstream IκB kinase (IKK), specifically inhibiting the IκB phosphorylation and degradation and the subsequent nuclear translocation of NF-κB

1049743-58-9
DCC4277 Ps121912

Highly potent and selective VDR-coactivator inhibitor

1529814-60-5
DCC4278 Psammaplysene B

Naturally occurring inhibitor of FOXO1a nuclear export

865722-85-6
DCC4279 Psammaplysin F

Unique inhibitor of bacterial chromosomal partitioning, increasing the efficacy of bortezomib and sorafenib through regulation of stress granule formation

DCC4280 Psb-1011

Potent competitive antagonist and positive modulator of the P2X2 receptor with >100-fold selectivity versus P2X4, P2X7, and several investigated P2Y receptor subtypes (P2Y(2,4,6,12))

4499-01-8
DCC4281 Psb-10129

Positive modulator of ATP effects at P2X2 receptors

DCC4282 Psb-10211

Potent competitive antagonist and positive modulator of the P2X2 receptor

66295-57-6
DCC4283 Psb-12105

Novel fluorescent-labeled selective adenosine A2B receptor antagonist

DCC4284 Psb-1410

Highly potent, selective, competitive, and reversible inhibitor of monoamine oxidase B (MAO-B)

1494477-03-0
DCC4285 Psb-1434 Featured

Highly potent, selective, competitive, and reversible inhibitor of monoamine oxidase B (MAO-B)

1619884-65-9
Page 1416 / Total 1558 FirstPrevNextLastGoto